OR WAIT null SECS
March 10, 2022
Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
UCB has announced it will build a new innovative gene therapy facility in Belgium.
March 09, 2022
Spectrum Chemical has further expanded its bioCERTIFIED product portfolio to support the growing global demand for new vaccines and therapeutics.
March 08, 2022
Amgen has announced the groundbreaking of its newest biomanufacturing facility in North Carolina.
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.
G-CON’s signature standardPOD cleanrooms will now be available in Europe.
Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
What if we are underestimating China’s response to US/EU inshoring?